Role of Selective Sodium-Glucose Co-Transporter-2 Inhibitors in Managing Cardio-Renal Complications in Type 2 Diabetes Mellitus: Beyond Glycemic Control

Chronic kidney disease (CKD) and cardiovascular complications are the leading causes of death in type 2 diabetes mellitus. Apart from the standard therapy, which includes angiotensin-converting enzyme inhibitors (ACEi), angiotensin receptor blockers (ARBs), lipid-lowering medication, and anti-platel...

Descripción completa

Detalles Bibliográficos
Autores principales: Onyali, Chike B, Anim-Koranteng, Comfort, Shah, Hira E, Bhawnani, Nitin, Ethirajulu, Aarthi, Alkasabera, Almothana, Mostafa, Jihan A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475743/
https://www.ncbi.nlm.nih.gov/pubmed/34603858
http://dx.doi.org/10.7759/cureus.17452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475743/
https://www.ncbi.nlm.nih.gov/pubmed/34603858
http://dx.doi.org/10.7759/cureus.17452

Ejemplares similares